Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMPL-760 Plus R-GemOx in R/R DLBCL
NCT06601504Phase 2Completed
- Sponsor
- HUTCHMED
- Start
- Nov 2024
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HMPL-760 in diffuse large B-cell lymphoma (DLBCL), sponsored by HUTCHMED. Started Nov 2024; status: completed.
02
Drugs
HMPL-760
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT06601504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06601504.